Proton therapy may be better option for elderly patients with esophageal cancer
(Mayo Clinic) A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 24, 2017 Category: Cancer & Oncology Source Type: news

Proton therapy may be better option for elderly patients with esophageal cancer
CHICAGO ? A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. Standard X-ray radiation therapy techniques include 3-D conformal radiation and intensity-modulated [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 24, 2017 Category: Databases & Libraries Source Type: news

Proton therapy lowers treatment side effects in pediatric head and neck cancer patients
(University of Pennsylvania School of Medicine) Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2017 Category: Cancer & Oncology Source Type: news

Northwestern Medicine Chicago Proton Center hosts 4th Annual PTCOG-NA Conference in Chicago
(Northwestern Memorial HealthCare) The Northwestern Medicine Chicago Proton Center will host over 200 leading clinicians, physicists and researchers in the growing field of proton therapy at the 4th Annual Particle Therapy Co-Operative Group North-America (PTCOG-NA) Conference, being held Oct. 23-25, 2017 at the Swiss ô tel Chicago. Conference participants will share the latest clinical, scientific and industrial developments in particle beam therapy, an advanced form of radiation therapy using beams of protons to destroy cancer cells and diseased tissue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 19, 2017 Category: International Medicine & Public Health Source Type: news

IBA, Elekta join forces on software development
Proton therapy firm Ion Beam Applications (IBA) and radiation oncology vendor...Read more on AuntMinnie.comRelated Reading: IBA posts half-year revenue increases Elekta adds members to MR-Linac Consortium Elekta promotes 21 studies at AAPM 2017 Elekta to install Bhutan's 1st linear accelerator Philips, Varian, IBA partner on Singapore cancer center IBA inks Va. installation deal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 25, 2017 Category: Radiology Source Type: news

Elekta inks stereotactic development, software, co-marketing deals
Medical software and equipment company Elekta has signed separate deals with Ion Beam Applications and Brainlab to share and integrate their technologies. In the memorandum of understanding with Ion Beam Applications, the two companies agreed to collaborate on investment in software development and the sale and marketing of each other’s products through a joint portfolio. Elekta specializes in technological solutions for improving, prolonging and saving the lives of patients with cancer and brain disorders, while IBA develops solutions for the diagnosis and treatment of cancer. Specifically, the companies plan to focus o...
Source: Mass Device - September 25, 2017 Category: Medical Devices Authors: Alex Beall Tags: Business/Financial News Wall Street Beat Elekta Source Type: news

Mevion files for FDA clearance for S250i proton therapy system
Mevion Medical Systems said yesterday it submitted a 510(k) premarket notification to the FDA for its Mevion S250i proton therapy system with Hyperscan pencil beam scanning tech. The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for faster energy layer switching, the Littleton, Mass.-based company said. “We focused on addressing the challenges clinicians faced with 1st generation systems and engineered a novel and transformative solution,” CEO Joseph Jachinowski said in a press release. The system also features the company’s Adaptive Aperture ...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Oncology Regulatory/Compliance Mevion Medical Systems Source Type: news

Mevion submits 510(k) to FDA for proton therapy system
Mevion Medical Systems has submitted a 510(k) premarket notification to the...Read more on AuntMinnie.comRelated Reading: Mevion touts scanning milestone Mevion joins forces with MedPhoton Mevion completes milestone installation Mevion completes Fla. installation Mevion, RaySearch partner on info system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2017 Category: Radiology Source Type: news

MedLever and HKSH collaborate for new MR-guided proton therapy solution
MedLever and the Hong Kong Sanatorium& Hospital (HKSH) have collaborated to develop the information backbone to support the new MR-guided proton therapy solution, which is being developed at the hospital. (Source: Hospital Management)
Source: Hospital Management - September 12, 2017 Category: Hospital Management Source Type: news

Brain imaging can't prove chronic pain
A task force of the International Association for the Study of Pain has concluded...Read more on AuntMinnie.comRelated Reading: fMRI, EEG may detect consciousness in TBI patients EEG device could reduce head CT scans Calif. center to explore proton therapy for pain relief Diagnosing chronic back pain: More than just looking at images MR spots reason for chronic groin pain, but may not alter management (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 11, 2017 Category: Radiology Source Type: news

IBA posts half-year revenue increases
Proton therapy firm Ion Beam Applications (IBA) posted revenue increases for...Read more on AuntMinnie.comRelated Reading: Philips, Varian, IBA partner on Singapore cancer center IBA inks Va. installation deal IBA to show updated synthesizer at SNMMI 2017 IBA posts healthy Q1 revenue rise IBA Molecular forms Curium as new radiopharmacy player (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 24, 2017 Category: Radiology Source Type: news

Belgium ’ s Ion Beam Applications dives on slowing growth
(Reuters) — Belgian proton therapy specialist Ion Beam Applications (EBR:IBAB) lost a third of its $1 billion market value today after it cut its guidance for 2018 and 2019, blaming project delays and increased competition. The company is a leading maker of machines that deliver cancer-fighting proton beams, a super-precise form of radiation, but it has been beset by delays in the construction of buildings to house its proton therapy systems by third-party contractors. IBAB shares closed down -35.1% at €20.00 ($23.64) apiece today in Brussels. “The first half of 2017 has been slower, in line with the customary l...
Source: Mass Device - August 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Radiosurgery Wall Street Beat ionbeamapplications Source Type: news

$1B Hamlin community 1 step closer to getting proton therapy center
The new facility will create about 100 new clinical and administrative jobs. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 21, 2017 Category: Health Management Authors: Veronica Brezina Source Type: news

$1B Hamlin community 1 step closer to getting proton therapy center
The new facility will create about 100 new clinical and administrative jobs. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Veronica Brezina Source Type: news

Proton Therapy Insurance Coverage: Fair or Foul? Proton Therapy Insurance Coverage: Fair or Foul?
At one center, the vast majority of requests for coverage for treatment of a set of cancers were approved, although some approvals required going through an appeal process. But was this well done?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news